| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on February 27, 2006
Accepted on April 24, 2006
Endocrine Institute and Department of Medicine E, Rabin Medical Center, Beilinson Campus, Petah-Tiqva 49100, Israel; Geha Mental Health Center, Petah-Tiqva 49100, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, Israel
* To whom correspondence should be addressed. E-mail: leibovic{at}post.tau.ac.il.
Context: In some patients symptoms of hypothyroidism persist despite therapy with thyroxine (T4).
Objective: To compare the effectiveness of thyroxine-triiodothyronine (T4-T3) combination vs. T4 monotherapy for the treatment of clinical hypothyroidism in adults.
Data sources: Pub Med, EMBASE, LILACS, and The Cochrane Central Register of Controlled Trials (CENTRAL) databases were searched in September 2005. References of all included trials were scanned for additional studies. We put no restrictions on language, year of publication, or publication status.
Study selection: All randomized trials that compared the effectiveness of thyroxine-triiodothyronine combination vs. thyroxine monotherapy for the treatment of clinical hypothyroidism in adults were included.
Data extraction: By 2 independent reviewers.
Data synthesis: We included 11 studies, in which 1216 patients were randomized. No difference was found in the effectiveness of combination vs. monotherapy in any of the following symptoms: bodily pain (standardized mean difference (SMD) 0.00, 95% confidence interval (CI) -0.34, 0.35), depression (SMD 0.07; 95% CI -0.20, 0.34), anxiety (SMD 0.00, 95% CI -0.12, 0.11), fatigue (SMD -0.12, 95% CI -0.33, 0.09), quality of life (SMD 0.03, 95% CI -0.09, 0.15), body weight, total serum cholesterol, triglyceride levels, LDL and HDL. Adverse events did not differ between regimens.
Conclusions: T4 monotherapy should remain the treatment of choice for clinical hypothyroidism.
This article has been cited by other articles:
![]() |
J. Jonklaas, B. Davidson, S. Bhagat, and S. J. Soldin Triiodothyronine Levels in Athyreotic Individuals During Levothyroxine Therapy JAMA, February 20, 2008; 299(7): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Cooper Thyroxine Monotherapy After Thyroidectomy: Coming Full Circle JAMA, February 20, 2008; 299(7): 817 - 819. [Full Text] [PDF] |
||||
![]() |
P. Saravanan, T. J. Visser, and C. M. Dayan Psychological Well-Being Correlates with Free Thyroxine But Not Free 3,5,3'-Triiodothyronine Levels in Patients on Thyroid Hormone Replacement J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3389 - 3393. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |